BRIEF-Novavax reschedules 4th annual investor, analyst meeting By: Reuters: Company News October 07, 2016 at 08:36 AM EDT * Continue to analyze data from resolve clinical trial, map out clinical path forward for older adult RSV F vaccine Read More >> Related Stocks: Novavax Inc